My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$ALXN {{ '2016-04-28T15:21:07+0000' | timeago}} • Announcement

$ALXN now expects 2016 total revenues in low end of its previously guided range of $3.05-3.10Bil, primarily due to increased macroeconomic weakness in Latin America, partially offset by rise in Strensiq revenues and strengthening of foreign currencies. $ALXN sees 2016 non-GAAP EPS to be at low end of prior forecast of $5.00-5.20.

User Johney Kingston {{ '2017-02-27T20:48:18+0000' | timeago}}

$WMT has indeed intensified the grocery price competition..Watch out $KR and Aldi.

User Felix Nilsson {{ '2017-02-27T20:41:52+0000' | timeago}}

The increasing US oil output seems to offset the bets raised by investors a week ago on increasing Brent crude oil prices.

User Nick Velez {{ '2017-02-27T20:22:11+0000' | timeago}}

Treasury yields moved higher on Monday as investors were cautious to make big government bonds investments ahead of President Donald Trump's first congressional address.

User Mark Collas {{ '2017-02-27T19:25:42+0000' | timeago}}

There is a chance the FCC might not review the $T-$TWX merger in which case it will probably go through.

User Josh Allan {{ '2017-02-27T14:53:18+0000' | timeago}}

Just two more days to go for Snapchat IPO! Any guesses on the opening price?

$PRGO {{ '2017-02-27T22:33:32+0000' | timeago}} • Webcast

$PRGO said that in the Consumer Healthcare business, it has been seeing certain pricing pressure. Therefore, across categories $PRGO competes in, it has competitive pricing. The company expects pricing pressure to continue in different segments going forward. But given the growth in new products, $PRGO expects to overcome the pricing challenges.

$PCLN {{ '2017-02-27T22:31:15+0000' | timeago}} • Webcast

$PCLN is pleased with the top line strength in its forecast. There is some pressure on the bottom line in 1Q17 where the company gets the gross bookings and incurs the advertising expense but a significant portion is going to check out in 2Q17 and 3Q17 and beyond when travel occurs. $PCLN expects the gross bookings to turn into gross profits.

$GMED {{ '2017-02-27T22:20:49+0000' | timeago}} • Announcement

$GMED's worldwide sales for 4Q16 increased 6.3% YoY to $151.6MM. Sales in the U.S. fell 2.7% YoY, primarily due to one less selling day in the quarter. International sales increased by 109%.

$GMED {{ '2017-02-27T22:20:23+0000' | timeago}} • Announcement

$GMED projects 2017 sales of $625MM and non-GAAP fully diluted EPS of $1.27. At the end of 4Q16, the company had cash, cash equivalents and marketable securities of $350.8MM, with debt free.

$PRGO {{ '2017-02-27T22:18:58+0000' | timeago}} • Webcast

For 2017, in the Rx segment, $PRGO expects to launch more than five products with branded sales of greater than $800MM. In the CAC International segment, the company expects approx. $1.4Bil in 2017 net sales, while operating margin percentage in the segment is expected in the low teens.